Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $197,937 - $306,649
-7,672 Reduced 9.33%
74,525 $2.21 Million
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $1.22 Million - $1.8 Million
-53,258 Reduced 39.32%
82,197 $1.93 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $1.87 Million - $4.39 Million
73,372 Added 118.18%
135,455 $3.68 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $370,979 - $518,317
-8,497 Reduced 12.04%
62,083 $3.34 Million
Q2 2022

Aug 11, 2022

SELL
$28.82 - $77.35 $4.01 Million - $10.8 Million
-139,132 Reduced 66.34%
70,580 $2.85 Million
Q1 2022

May 13, 2022

SELL
$48.25 - $100.49 $4.05 Million - $8.43 Million
-83,900 Reduced 28.58%
209,712 $13.9 Million
Q4 2021

Feb 10, 2022

SELL
$88.71 - $120.43 $4.11 Million - $5.57 Million
-46,282 Reduced 13.62%
293,612 $29.4 Million
Q3 2021

Nov 12, 2021

SELL
$98.77 - $132.17 $3.92 Million - $5.25 Million
-39,715 Reduced 10.46%
339,894 $42.5 Million
Q2 2021

Aug 12, 2021

BUY
$109.77 - $165.68 $8.42 Million - $12.7 Million
76,743 Added 25.34%
379,609 $47.1 Million
Q1 2021

May 12, 2021

BUY
$127.04 - $179.1 $15.7 Million - $22.1 Million
123,625 Added 68.97%
302,866 $46.2 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $1.69 Million - $2.29 Million
16,858 Added 10.38%
179,241 $23.1 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $2.88 Million - $4 Million
35,822 Added 28.3%
162,383 $18.2 Million
Q2 2020

Aug 13, 2020

BUY
$60.49 - $97.5 $1.29 Million - $2.07 Million
21,267 Added 20.2%
126,561 $10.3 Million
Q1 2020

May 14, 2020

SELL
$59.04 - $88.81 $285,871 - $430,018
-4,842 Reduced 4.4%
105,294 $7.33 Million
Q4 2019

Feb 14, 2020

BUY
$59.49 - $82.78 $914,658 - $1.27 Million
15,375 Added 16.23%
110,136 $8.61 Million
Q3 2019

Nov 14, 2019

SELL
$62.59 - $110.3 $1.57 Million - $2.77 Million
-25,087 Reduced 20.93%
94,761 $6.05 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $651,932 - $928,957
10,196 Added 9.3%
119,848 $10.3 Million
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $18,350 - $52,419
535 Added 0.49%
109,652 $8.41 Million
Q4 2018

Feb 12, 2019

BUY
$29.2 - $46.1 $3.19 Million - $5.03 Million
109,117 New
109,117 $4.1 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.92B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.